Teva paid top executives $330m while share price tanked - Globes
Teva CEO exits in ongoing crisis of confidence at drugmaker | Reuters
Teva decided to appoint Richard Francis as President and CEO replacing Kar Schultz after 5 years :: Israeli Financial News - The Israeli Economic World
New Teva CEO reorganizes with an 'ax, not hedge clippers or pruning shears' - STAT
Israel's Teva Pharm to start paying US opioid settlement in 2023 -CEO - The Jerusalem Post
Teva CEO Erez Vigodman Steps Down | CHEManager
Teva CEO on Advancing Health Care | BCG
Where is Kåre Schultz? | Ctech
Teva names Richard Francis to replace CEO Schultz - Medical Buyer
Teva CEO Richard Francis, after 120 days at the helm, preps grand strategic reveal
Teva CEO says production and distribution in Israel remain largely unaffected by war | The Times of Israel
Teva CEO steps down, replacement found — MedWatch
Schultz kept Teva away from the abyss, but couldn't find a runway to growth | Ctech
Teva Pharmaceutical Industries names a new CEO
INTERVIEW - Richard Francis, CEO of Teva Pharmaceutical: solid quarter, full-year forecasts raised -August 02, 2023 at 03:19 pm EDT | MarketScreener
Teva Pharmaceuticals on LinkedIn: #jpm #jpm2024 #tevapharm #fiercejpmweek #fiercebiotech #fiercepharma…
Troubled Teva appoints new CEO in bid for direction | The Times of Israel
Teva Pharm to stay as unified drugmaker, sees big interest in API business, says CEO | Reuters
Teva Pharmaceuticals on X: "Speaking at #JPM2020, Teva CEO Kåre Schultz discussed the company's restructuring, future growth drivers, and a focus on the needs of patients and customers. Listen to a replay
Teva has made short work of its hunt for a new CEO
Teva's new CEO Schultz to take post Wednesday | The Times of Israel
Teva Pharmaceuticals CEO on the Covid-19 vaccine rollout in Israel
Teva CEO: Israel's production capacity has not been affected by the war | Ctech
Teva Names Interim CEO, New Chairman As Vigodman Steps Down
Teva hires ex-Novartis executive to succeed CEO Schultz | Reuters
Teva Pharmaceutical to Replace CEO Kare Schultz - WSJ
Five Things Facing Teva's New CEO Richard Francis :: Generics Bulletin
